Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00734877
Title UARK 2008-01, Total Therapy 4 - A Phase III Trial for Low Risk Myeloma
Acronym TT4B
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Arkansas
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.